Requests for Medical Information. Cardiome shall have the exclusive right and responsibility to respond to all questions and requests for information regarding Product received by the Sales Force or any MSL from prescribers or health care providers in the Territory in accordance with Commercialization Standards and Applicable Laws.
Requests for Medical Information. Eagle shall have the exclusive right and obligation to respond, in accordance with Applicable Laws and the Codes (as applicable), to all questions or requests for information about any Product that are outside of the Label made by any Healthcare Professional, Healthcare Organization or any other Third Party to the CAMs or other Spectrum Personnel (each, a “Product Information Request” or “PIR”). With respect to a Product Information Request received by a CAM or other Spectrum Personnel, such Spectrum Personnel shall promptly refer such PIRs to Eagle’s call center for response. For clarity, PIRs shall not be proactively solicited by CAMs or other Spectrum Personnel. For any PIR received by Spectrum’s call center, Spectrum shall promptly transfer such PIR to Eagle’s call center. Eagle shall promptly provide Spectrum with a copy of any written materials provided by Eagle in response to a PIR or a summary of any oral discussions provided by Eagle in response to a PIR.
Requests for Medical Information. Sanofi shall have the exclusive right to respond to all questions or requests for information about the Co-Promotion Product(s) made by any medical professionals or any other Person to MyoKardia or its sales representatives that (a) warrant a response beyond the understanding or knowledge of such sales representative or (b) are beyond the scope of the product labeling or other Promotional Materials for such Co-Promotion Product(s) (each, a “PIR”). Upon MyoKardia’s request, Sanofi shall provide such PIR to MyoKardia at no cost to MyoKardia. MyoKardia shall, and shall cause its sales representatives to, promptly communicate to the Sanofi Information Center or Medical Resources Department all PIRs received by MyoKardia or such sales representatives. In connection with the Co-Promotion of the Co-Promotion Product(s), MyoKardia shall cause its sales representatives to inform prescribers and purchasers (if any) that they may contact the Sanofi Information Center regarding questions or requests for information about the Co-Promotion Product(s) by telephone or by completing a medical resource form and transmitting the completed form directly to Sanofi Medical Resources as provided on such form.
Requests for Medical Information. 13.4.1 Abraxis shall have the exclusive right to respond to all questions or requests for information about the Product made by any medical professionals or any other Person to AstraZeneca or its Representatives that (i) warrant a response beyond the understanding or knowledge of such Representative or (ii) are beyond the scope of the Product Labels and Inserts or other Promotional Materials (a “PIR”).
Requests for Medical Information. (a) Notwithstanding anything in this Agreement or the Business Policies to the contrary, no Program Employee may respond to or otherwise communicate with any Target Prescriber or other Third Party with respect to any Off-Label Information []*.
Requests for Medical Information. When an RA request is made, EPA is entitled to know that an applicant or employee has a covered disability that requires reasonable accommodation. Medical information as documentation is not always needed in order to approve an RA request. There are several ways EPA may seek medical information in order to process an employee's request for a workplace RA. The X-X and/or the NRAC, may ask the employee for medical information, via the interactive process, regarding the employee's need for accommodation. If a X-X believes that medical information as documentation will be required in order to process a request, s/he must immediately contact the NRAC for a full discussion of the procedures, time frames and requirements for processing RA requests. The RAC will ensure the interactive process has been engaged with the requesting employee. When D-Ms use the interactive process, s/he must document any RA options that are discussed with or offered to the requesting employee. Once the NRAC or X-X has obtained the requested medical information and/or a final determination has been made to approve a requested accommodation, EPA may not ask for additional medical information in support of the approved request. Additional medical information may not be requested unless there is a new RA request made by the employee, which can be considered, as explained below, a case where medical information is necessary.
Requests for Medical Information. (a) AstraZeneca shall have the exclusive right and responsibility to respond to all PIRs received by the Sales Force or any MSL.
Requests for Medical Information. The Agreement is hereby amended so that Section 3.8(a) is deleted in its entirety and replaced with the following: “Notwithstanding anything in this Agreement or the Business Policies to the contrary, no Program Employee may respond to or otherwise communicate with any Target Prescriber or other Third Party with respect to any Off-Label Information []*.”
Requests for Medical Information. Regardless of Co-Promotion option status (exercise or not) MERCK shall have the exclusive right to respond, in written communications, to all unsolicited questions or requests that it receives from physicians, pharmacists or other healthcare professionals about Co-Promoted Products to the extent that such requests cannot be addressed by referring to the prescribing information, approved reprints or other approved literature (a “Professional Information Request” or “PIR”). MERCK shall use Commercially Reasonable Efforts to respond to PIR requests within [***] ([***]) business days of the request and will copy ARIAD on all such responses. If, during the term of the Co-Promotion Agreement, ARIAD receives such requests for Medical Information from customers for a Co-Promoted Product, it shall refer all such requests to MERCK.
Requests for Medical Information. (a) AZ shall have the exclusive right to respond to all questions or requests for information about the Products made by any medical professionals or any other Person to the Company or a Representative that (i) warrant a response beyond the understanding or knowledge of the Representative or (ii) are beyond the scope of the Product Labels and Inserts or other Promotional Materials (a "PIR").
